In the realm of cancer diagnosis and treatment, the advent of liquid biopsy has sparked a transformative shift. Liquid biopsy, a term encompassing the collection…
Tag: ctdna
Circulating tumor DNA (ctDNA) is a key biomarker in liquid biopsy that enables the analysis of tumor-derived genetic alterations from blood samples. Explore Genes2Me articles covering ctDNA testing, NGS-based liquid biopsy, cancer biomarkers, molecular oncology, and advances in precision medicine.